Rachel Glincher

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The antivascular endothelial growth factor antibody, bevacizumab, is effective against several malignancies in adults but unproven in pediatric oncology. In early phase pediatric studies toxicities were similar to those in adults. Bowel perforation in adults is a rare but serious toxicity, but has not been hitherto reported in children. A 5-year-old boy(More)
  • 1